Fundz

N-Power Medicine raised $72 Million in a Series B funding round led by Merck Global Health Innovation Fund

PRIVATEJul 01, 2024

Amount Raised

$72 Million

Round Type

Series B

Redwood CityBiotechnologyHealth CareMedicalTherapeuticsPharmaceutical

Investors

Merck Global Health Innovation Fund

Description

N-Power Medicine, a clinical research and drug development platform company, has announced the initial close of its Series B funding round, with participation by a US-based healthcare focused investor. The funding round led by Merck Global Health Innovation Fund brings its total funding to date to $72 Million.

Quick answer

N-Power Medicine raised $72 Million in a Series B round, dated July 1, 2024. Investors: Merck Global Health Innovation Fund. N-Power Medicine is based in Redwood City, California, United States.

How much did N-Power Medicine raise?
N-Power Medicine raised $72 Million in a Series B round on July 1, 2024.
Who invested in N-Power Medicine?
Merck Global Health Innovation Fund is named as investors in this round.
What does N-Power Medicine do?
N-Power Medicine is a clinical research and drug development platform company that aims to integrate clinical research and routine care into a single workflow.
Where is N-Power Medicine based and how big is it?
N-Power Medicine is based in Redwood City, California, United States. Fundz records about 57 employees.
Who are the decision-makers at N-Power Medicine?
Fundz holds 1 contact at N-Power Medicine, including the CEO & Co-Founder. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as N-Power Medicine that raised within 45 days of this round, from Fundz verified event records.

  • Lipella Pharmaceuticals raised $120K on July 31, 2024.
  • IDRx raised $120M (Series B) on August 7, 2024.
  • Amporin Pharmaceuticals raised $170K (Grant) on July 26, 2024.
  • Pelthos Therapeutics raised $750K on July 24, 2024.
  • Ensho Therapeutics raised $400K on July 19, 2024.
  • Renalys Pharma raised $38M (Series A) on July 17, 2024.

Who to call at N-Power Medicine, and when

A new round usually means N-Power Medicine is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day N-Power Medicine raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at N-Power Medicine, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at N-Power Medicine. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

N-Power Medicine

Location

Redwood City, California, United States

About

N-Power Medicine is a clinical research and drug development platform company that aims to integrate clinical research and routine care into a single workflow. Founded in 2021, it aims to boost clinical trial participation to accelerate oncology drug development. The company's platform includes The Kaleido Registry, a collection of prospective, real-time, standardized patient data designed to support clinical trials and drug development.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment N-Power Medicine raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMark, CEO & Co-Founder hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for N-Power Medicine's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

N-Power Medicine raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.